NIH-funded research R01 grant

Real-world safety and decision help for new Alzheimer's treatments

Official title: Improving Informed Decision Making Through Real-World Safety Monitoring of New Alzheimer's Treatments

Funded at Hebrew Rehabilitation Center for Aged · NIH-11448523 · Data updated 2026-11-12

This grant looks at how monoclonal antibody drugs for Alzheimer’s affect people in real life and creates a practical decision aid for patients and families.

More Decision Making research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHebrew Rehabilitation Center for Aged
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 15, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$671,336
NIH project number1R01AG094761-01A1
Project IDNIH-11448523 on NIH RePORTER

Who could benefit from this research

Could help

Adults 65 and older who have or are considering monoclonal antibody therapy for Alzheimer’s disease.

Less likely to help

Individuals not considering or receiving monoclonal antibody therapy for Alzheimer’s may not directly benefit from the decision aid.

What this research studies

Many older adults with Alzheimer’s face complex choices about amyloid-targeting therapies because these drugs can slow symptoms but also cause serious risks and require ongoing testing. The project will use Medicare data and real-world electronic health records to understand the everyday treatment burden and safety concerns outside clinical trials. Researchers will combine findings with patient-facing tools to help people weigh benefits, risks, costs, and preferences before starting therapy. The work aims to support clearer, personalized decisions for patients and caregivers.

Why it matters

Potential benefit: Patients could have clearer, personalized guidance when considering these treatments, helping them balance benefits and risks.

How similar studies have gone: There is growing evidence on real-world safety of these therapies, but comprehensive decision aids in real-world settings are limited.

Where this research is happening

  • Hebrew Rehabilitation Center for Aged
    Boston, United States
    Active

Researchers

  • Principal investigator: Kim, Dae Hyun — Hebrew Rehabilitation Center for Aged
  • Study coordinator: Kim, Dae Hyun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.